Literature DB >> 8314441

A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice.

S Bieg1, E M Bailyes, N Yassin, J Amann, L Herberg, A M McGregor, W A Scherbaum, J P Banga.   

Abstract

Type 1 (insulin-dependent) diabetes mellitus is a T-cell mediated autoimmune disease with a number of different proteins being implicated as target autoantigens. A 38 kDa protein residing in the insulin secretory granule of insulinoma tissue is recognized by T-cell clones from a newly-diagnosed Type 1 diabetic patient. We have investigated the capacity of normal rat pancreatic beta-cell extracts and various subcellular fractions of transplantable RIN tissue to induce proliferation of T cells from non-obese diabetic (NOD) mice and H-2 identical NON.NOD-H-2g7 control mice. Normal rat islet beta-cell protein fractions induced intense, dose-dependent proliferation of NOD splenic T cells, but only marginal proliferative responses of NON.NOD-H-2g7 splenic T cells. To further localize the target antigens, four different subcellular fractions from RIN tissue were used as a source of antigen; here in particular the cytosolic proteins showed dose-dependent activation capacity with splenic T cells in NOD animals. These activities were absent in control mice. There was no proliferation after incubation with microsome preparations from other rat endocrine tissues. Purified carboxypeptidase H did not have any stimulatory activity on NOD T cells. Fractionation of the RIN cytosolic proteins showed a large number of different fractions eliciting proliferative activity. These results demonstrate that NOD T cells respond to a large number of potential islet beta-cell target antigens and it will be necessary to utilize NOD T-cell clones to identify the number and nature of these antigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314441     DOI: 10.1007/bf00402272

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Isolation of pancreatic islets and primary culture of the intact microorgans or of dispersed islet cells.

Authors:  C B Wollheim; P Meda; P A Halban
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors:  L Castaño; G S Eisenbarth
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.

Authors:  D Elias; D Markovits; T Reshef; R van der Zee; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Pancreatic islet-specific T-cell clones from nonobese diabetic mice.

Authors:  K Haskins; M Portas; B Bergman; K Lafferty; B Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Type I diabetes in NOD mice is not associated with insulin-specific, autoreactive T cells.

Authors:  U Hurtenbach; C Maurer
Journal:  J Autoimmun       Date:  1989-04       Impact factor: 7.094

6.  Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.

Authors:  O Pankewycz; T B Strom; V E Rubin-Kelley
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

7.  Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Genovese; E Bonifacio; J M McNally; B M Dean; R Wagner; E Bosi; E A Gale; G F Bottazzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

8.  Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction.

Authors:  P Bedossa; A Bendelac; J F Bach; C Carnaud
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

9.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice.

Authors:  N Nakano; H Kikutani; H Nishimoto; T Kishimoto
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  5 in total

1.  Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice.

Authors:  V Menard; H Jacobs; H S Jun; J W Yoon; S W Kim
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Evidence for recognition of novel islet T cell antigens by granule-specific T cell lines from new onset type 1 diabetic patients.

Authors:  T I Tree; D O'Byrne; J M Tremble; W M MacFarlane; K Haskins; R F James; K Docherty; J C Hutton; J P Banga
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

3.  Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.

Authors:  P Saï; O Senecat; L Martignat; E Gouin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  HLA-DR-restricted T cell lines from newly diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: lack of reactivity to glutamic acid decarboxylase.

Authors:  G C Huang; J Tremble; E Bailyes; S D Arden; T Kaye; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

5.  Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient.

Authors:  S D Arden; B O Roep; P I Neophytou; E F Usac; G Duinkerken; R R de Vries; J C Hutton
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.